CompositionRabishield 100 Injection is used to provide immediate protection against the rabies virus following suspected exposure, such as an animal bite or scratch. It contains Rabies Human Monoclonal Antibody, which works by neutralizing the virus at the site of exposure before it can infect the nervous system. This is a crucial part of post-exposure prophylaxis (PEP).
This treatment is essential for individuals who have not been previously vaccinated against rabies. It provides the "passive immunity" needed until the rabies vaccine can trigger the body's own immune response. The injection is administered by a healthcare professional and should be given as soon as possible after exposure for maximum effectiveness.
